molecular structure

Opiant in the news

October 10, 2018 – Opiant CEO Dr. Roger Crystal discusses teaming with HHS on new opioid overdose nasal spray.

August 3, 2018 – Opiant CEO Dr. Roger Crystal discusses NARCAN® following singer Demi Lovato’s hospitalization.

July 26, 2018 – Opiant CEO Dr. Roger Crystal explains how NARCAN® works following singer Demi Lovato’s hospitalization.

May 14, 2018 – Opiant CEO Dr. Roger Crystal discusses the fentanyl threat and the Company’s work to combat the opioid crisis.

February 13, 2018 – Opiant CEO Dr. Roger Crystal discusses the Company’s work on a new nasal spray for opioid overdose that targets longer-acting and more potent synthetic opioids, including fentanyl.

December 20, 2017 – Opiant CEO Dr. Roger Crystal addresses the opioid crisis, the role of NARCAN® Nasal Spray and the Company’s other work in addiction, including heroin and alcohol.

November 5, 2017 – Opiant CEO Dr. Roger Crystal addresses addiction and the opioid crisis, the role of NARCAN® Nasal Spray, and the early work on a heroin vaccine.

October 26, 2017 – Opiant CEO Dr. Roger Crystal discusses the Company’s role in combating addiction and the opioid crisis, a “public health emergency” as declared by President Trump.

October 6, 2017 – Opiant CEO Dr. Roger Crystal calls on Washington to partner with the pharma industry to tackle the opioid crisis.

September 29, 2017 – Opiant CEO Dr. Roger Crystal speaks with radio station KCRW about opioids, doctors and drug addiction.